Skip to main content
Clinical Trials/NCT00809523
NCT00809523CompletedPhase 2

A Multicenter, Randomized Controlled Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

Yale University8 sites in 3 countries106 target enrollmentStarted: December 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
106
Locations
8
Primary Endpoint
Percentage Change SIGH SAD Depression Rating

Study Overview

Brief Summary

This is a randomized, controlled clinical trial of inactivated negative ion generation or light-emitting photodiode therapy for Seasonal Affective Disorder (SAD, winter depression), for subjects with a DSM IV diagnosis of Major Depression, with Seasonal Pattern, Winter type, to examine efficacy of treatments for this condition. The trial has a 1 week baseline phase and a 4 week treatment phase.

Detailed Description

This is a randomized, controlled clinical trial comparing an inactivated negative ion generation (placebo condition) and light-emitting photodiode therapy (active condition), for Seasonal Affective Disorder (SAD, winter depression), for subjects with a DSM IV diagnosis of Major Depression, with Seasonal Pattern, Winter type, to examine efficacy of treatments for this condition. Exclusion criteria included any other current treatment for SAD, as well as bipolar disorder, type 1, a chronic psychotic disorder, or a substance use not if full remission for at least one year. The trial has a 1 week baseline phase and subjects were seen weekly during a 4 week treatment phase. The study was double-blind. The study was conducted at 8 sites in the US, Canada and The Netherlands.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Seasonal Affective Disorder
  • •Age 18 to 65

Exclusion Criteria

  • •Psychotropic medication treatment
  • •History of light treatment for SAD
  • •History of mania or psychosis

Arms & Interventions

Inactivated negative ion generator

Experimental

Equivalent exposure to inactivated Negative Ion Generator

Intervention: Negative Ion Generator (Device)

LED light treatment device

Experimental

Light-emitting photodiode light treatment device, used for 30 min before 8 am

Intervention: Light-emitting Photodiode light treatment device (Device)

Outcomes

Primary Outcomes

Percentage Change SIGH SAD Depression Rating

Time Frame: 4 weeks

SIGH SAD Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder (SAD)version. The items are augmented with additional items to reflect better the atypical depressive symptoms usually seen in SAD, eg, increased sleep, weight, appetite and fatigue. On this scale, higher scores reflect increased depression intensity. The maximum score attainable is 63, and the minimum is 0. A score of less than 9 is regarded as consistent with normal mood, the absence of major depression. Calculated: SIGH SAD score at trial end - SIGH SAD score at randomization x 100 / SIGH SAD score at randomization

Secondary Outcomes

  • SIGH SAD Depression Rating(Weekly)
  • Clinical Global Impression of Severity(Randomization and at 4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (8)

Loading locations...

Similar Trials

Recruiting
Not Applicable
A multicentre, randomized controlled trial of neurolysis for mild ulnar neuropathy at the elbowulnar neuropathy, neurolysis, conservative treatmentulnaropathie, neurolyse, conservatief beleid
NL-OMON27989dr. L.H. VisserSt Elisabeth Hospitalhilvarenbeekseweg 605022 GC Tilburgthe Netherlands013-5392552Fax 013-5422538E-mail l.visser@elisabeth.nldr. R. BeekmanAtrium Medical CentrePo Box 4446 6401 CX Heerlen the Netherlandsr.beekman@atriummc.nl045-5766700drs. A.H.C.M.L. SchreuderAtrium Medical CentrePo Box 4446 6401 CX Heerlen the NetherlandsTSR01@atriummc.nl045-5766700120
Completed
Not Applicable
A multicentre, randomized controlled trial of neurolysis for mild ulnar neuropathy at the elbowulnar neuropathynerve at elbow10034606
NL-OMON34554Sint Elisabeth Ziekenhuis120
Not yet recruiting
Phase 4
A multicenter, randomized, controlled, trial for efficacy of Chang-Yan-Ning granules in the treatment of functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)
ITMCTR2000002901Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Completed
Phase 3
A randomized, multicenter, controlled trial of the effectiveness of nebulized therapy with 3% hypertonic saline solution compared with 0.9% saline solution in hospitalized infants with RS viral bronchiolitis.RS viral bronchiolitis
JPRN-UMIN000001700Tokyo Metropolitan Children's medical center Hospital120
Completed
Not Applicable
The clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockSevere sepsis/septic shockInfections and InfestationsOther septicaemia
ISRCTN36307479Intensive Care National Audit and Research Centre (ICNARC) (UK)1,260